FindTrial
Sign In

Spice fixed oil nanoparticles to control dyslipidemia in humans subjects

Studies on the effect of spice fixed oil nanoemulsions to address dyslipidemia in human subjects - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089355
Enrollment
140
Registered
2025-06-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Spice fixed oil nanoemulsions: Normal control group Intervention2: Control diet: No test compound will be given Intervention3: Dyslipidemic condition: Negative control group, which are

Sponsors

CSIR CFTRI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: having a high triglycerides, cholesterol, LDL higher than 100 mg/dl and low HDL levels means less than 40 mg/dl.

Exclusion criteria

Exclusion criteria: Chronic illness Pregnancy/lactation Lipid-lowering drugs Spice allergies

Design outcomes

Primary

MeasureTime frame
Reduction in total cholesterol, LDL, triglycerides and Increase in HDL Timepoint: 0 and 60th day—

Secondary

MeasureTime frame
We can control the lipid levels in the bodyTimepoint: 2 months—

Countries

India

Contacts

Public ContactDr Vallamkondu Manasa

CSIR-CFTRI

manasa7396@gmail.com08867608676

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026